Mid-trimester amniotic fluid C-reactive protein, ferritin and lactate dehydrogenase concentrations and subsequent risk of spontaneous preterm labour.

Borna S, Mirzaie F, Abdollahi A.
Department of Fetal-Maternal Medicine, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.

BACKGROUND: Preterm delivery is a serious problem in obstetrics. A pre-existing inflammation in the first half of gestation has been proposed as a possible condition that leads to preterm delivery.

AIM: Our aim was to compare C-Reactive Protein (CRP), ferritin and lactate dehydrogenase (LDH) concentrations in mid-trimester amniotic fluid of patients with preterm and term deliveries and to found out their predictive values for preterm delivery.

METHODS: The study was conducted on 90 pregnant women who underwent genetic amniocentesis between the 15th and the 20th weeks of gestation. The samples were carried immediately to the laboratory for cytogenetic and biochemical examination. Non-parametric tests and receiver-operating characteristic curve analysis were used for statistical purpose.

RESULTS: This study showed women with preterm delivery at < 37 weeks (n = 17) had a higher median of amniotic fluid LDH concentration than those women who delivered at term (n = 73) (P = 0.003). Amniotic fluid LDH concentration of > 120 IU/L had a sensitivity of 59% and a specificity of 81% in the prediction of spontaneous preterm delivery at < 37 weeks. Maternal serum alpha fetoprotein levels were higher in patients delivered preterm compared with term deliveries (P = 0.036).

CONCLUSION: Mid-trimester LDH is found to be quite effective in the prediction of preterm delivery. Pre-existing intrauterine inflammatory process early in gestation may be an important risk factor for preterm delivery

HUMAN C- REACTIVE PROTEIN (CRP)

THE LATEST IN HUMAN C-REACTIVE PROTEIN (CRP) Research:
Transgenic expression of human C-Reactive Protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury.These in vivo observations support the hypothesis that CRP modulates NO metabolism and may have implications regarding the mechanisms by which CRP modulates vascular disease.Source: Am J Physiol Heart Circ Physiol 293: H489-H495, 2007

human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis.CRP also enhanced myeloma cell secretion of IL-6 and synergized with IL-6 to protect myeloma cells from chemotherapy drug-induced apoptosis. Thus, our results implicate CRP as a potential target for cancer treatment.Source: Cancer Cell, Vol 12, 252-265, 11 September 2007